Related Experiment Video
Updated: Jun 6, 2026
06:53
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
Published on: September 9, 2020
Giant cell tumor: Curettage and bone grafting
1Dept. of Orthopedics, Amala Institute of Medical Sciences, Amalanagar, Thrissur, Kerala - 680 555, India.
Indian Journal of Orthopaedics
|December 9, 2010
Summary
Curettage and bone grafting effectively treats giant cell tumors (GCT) of bone when specific case selection criteria are met. This method shows a low recurrence rate, making it a reliable surgical option for GCT.
Area of Science:
- Orthopedic Surgery
- Oncology
- Bone Tumors
Background:
- Giant cell tumor (GCT) of bone is a significant clinical challenge.
- Curettage and wide resection are standard treatment modalities.
- Variability in curettage success rates necessitates clear case selection guidelines.
Purpose of the Study:
- To analyze the outcomes of treating GCT of bone using curettage and bone grafting.
- To evaluate the efficacy of curettage with bone grafting in a cohort of patients.
- To establish criteria for selecting appropriate cases for curettage.
Main Methods:
- Retrospective analysis of 34 GCT cases (28 primary, 6 recurrent).
- Treatment involved curettage and bone grafting.
- Case selection based on Campanacci grade (1-3) and CT scan findings (cortical breach < 1/3 circumference, confined to one surface).
Main Results:
- A recurrence rate of 14% (4 out of 34 lesions) was observed after 1.5 years.
- The study demonstrates the feasibility of curettage and bone grafting for selected GCT cases.
Conclusions:
- Curettage and bone grafting is a reliable treatment for GCT of bone.
- Strict adherence to case selection guidelines and tumor surgery principles is crucial for successful outcomes.
- This approach offers a viable alternative for managing GCT when applied judiciously.
